iListed below are all new filings before PTAB of requests for inter partes review (IPR) and covered business methods review (CBM). Since the last report, no new requests for ex parte reexamination at the USPTO have been posted. This listing is current as of 10 AM on Tuesday, October 27, 2015.
New IPR Requests
Trial Number – IPR2016-00062
Filing Date – 10/26/2015
Patent # – 6,502,135
Title – AGILE NETWORK PROTOCOL FOR SECURE COMMUNICATIONS WITH ASSURED SYSTEM AVAILABILTY
Patent Owner – VIRNETX INC.
Petitioner – APPLE INC.
Tech Center – 2100
Trial Number – IPR2016-00063
Filing Date – 10/26/2015
Patent # – 7,490,151
Title – ESTABLISHMENT OF A SECURE COMMUNICATION LINK BASED ON A DOMAIN NAME SERVICE (DNS) REQUEST
Patent Owner – VIRNETX INC.
Petitioner – APPLE INC.
Tech Center – 2100
Trial Number – IPR2016-00074
Filing Date – 10/26/2015
Patent # – 7,741,338
Title – MACROLIDES
Patent Owner – NOVARTIS AG
Petitioner – Par Pharmaceutical, Inc.
Tech Center – 1600
Trial Number – IPR2016-00075
Filing Date – 10/26/2015
Patent # – 7,297,703
Title – MACROLIDES
Patent Owner – NOVARTIS AG
Petitioner – Par Pharmaceutical, Inc.
Tech Center – 1600
Trial Number – IPR2016-00078
Filing Date – 10/26/2015
Patent # – 6,455,518
Title – PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION, AUTOIMMUNE OR INFLAMMATORY CONDITIONS COMPRISING CYCLOSPORIN A AND 40-O-(2-HYDROXYETHYL)-RAPAMYCIN
Patent Owner – NOVARTIS AG
Petitioner – Par Pharmaceutical, Inc.
Tech Center – 1600
Trial Number – IPR2016-00084
Filing Date – 10/26/2015
Patent # – 5,665,772
Title – O-ALKYLATED RAPAMYCIN DERIVATIVES AND THEIR USE, PARTICULARLY AS IMMUNOSUPPRESSANTS
Patent Owner – NOVARTIS AG
Petitioner – Par Pharmaceutical, Inc.
Tech Center – 1200
Trial Number – IPR2016-00085
Filing Date – 10/26/2015
Patent # – 7,829,595
Title – RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND
Patent Owner – AMGEN INC.
Petitioner – COMPLEX INNOVATIONS, LLC
Tech Center – 1600
New CBM Review Requests
There have been no new requests for CBM review since the last report.
Newly-Posted Reexam Requests
There have been no new reexam requests posted since the last report.
